Article
Variation at interleukin-6 receptor gene is associated to joint damage in rheumatoid arthritis.
Arthritis research & therapy - 4 Sept 2015
Lopez-Lasanta Maria, Julià Antonio, Maymó Joan, Fernández-Gutierrez Benjamín, Ureña-Garnica Inmaculada, Blanco Francisco J, Cañete Juan D, Alperi-López Mercedes, Olivè Alex, Corominas Héctor, Tornero Jesus, Erra Alba, Almirall Miriam, Palau Nuria, Ortiz Ana, Avila Gabriela, Rodriguez-Rodriguez Luis, Alonso Arnald, Tortosa Raül, Gonzalez-Alvaro Isidoro, Marsal Sara
Abstract excerpt
INTRODUCTION: Interleukin-6 (IL-6) cytokine signaling is key in Rheumatoid Arthritis (RA) pathophysiology. Blocking IL-6 receptor (IL6R) has proven to be a highly effective treatment to prevent joint damage. This study was performed to investigate the association between the genetic variation at IL6R gene and the severity of joint damage in RA. METHODS: IL6R gene tagging SNPs (n = 5) were genotyped in a discovery...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
